Yatin Suneja
Stock Analyst at Guggenheim
(4.95)
# 137
Out of 4,531 analysts
403
Total ratings
58.5%
Success rate
33.6%
Average return
Main Sectors:
Stocks Rated by Yatin Suneja
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DBVT DBV Technologies | Reiterated: Buy | $51 | $14.70 | +246.94% | 7 | Jul 17, 2026 | |
| FBRX Forte Biosciences | Reiterated: Buy | $75 | $48.86 | +53.50% | 3 | Jul 9, 2026 | |
| ABVX ABIVAX Société Anonyme | Reiterated: Buy | $175 | $136.65 | +28.06% | 10 | Jul 1, 2026 | |
| PRAX Praxis Precision Medicines | Maintained: Buy | $800 | $314.41 | +154.44% | 16 | Jun 30, 2026 | |
| ZURA Zura Bio | Maintained: Buy | $15 | $5.45 | +175.23% | 6 | Jun 29, 2026 | |
| EYPT EyePoint | Reiterated: Buy | $68 | $13.30 | +411.28% | 9 | Jun 24, 2026 | |
| ARGX argenx SE | Reiterated: Buy | $1,135 | $860.55 | +31.89% | 24 | Jun 24, 2026 | |
| SION Sionna Therapeutics | Reiterated: Buy | $50 | $49.41 | +1.19% | 6 | Jun 23, 2026 | |
| CLYM Climb Bio | Initiated Coverage: Buy | $35 | $12.70 | +175.59% | 4 | Jun 8, 2026 | |
| ZBIO Zenas BioPharma | Maintained: Buy | $55 | $29.53 | +86.25% | 3 | Jun 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $75 → $45 | $12.19 | +269.16% | 2 | Jun 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $44 → $62 | $40.26 | +54.00% | 12 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 → $36 | $34.51 | +4.32% | 9 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $2.83 | +465.37% | 9 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $32 → $34 | $28.66 | +18.63% | 5 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 | $3.54 | +323.73% | 4 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $1.86 | +654.72% | 15 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $60 | $29.05 | +106.54% | 3 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $14 | $1.61 | +769.57% | 5 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $50 | $19.37 | +158.13% | 2 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 | $105.60 | +89.39% | 9 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $245 → $260 | $230.00 | +13.04% | 25 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $975 → $995 | $676.69 | +47.04% | 31 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $25 | $10.94 | +128.52% | 15 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $246 → $260 | $205.99 | +26.22% | 27 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $125 → $200 | $92.70 | +115.75% | 6 | Apr 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $70 | $15.16 | +361.74% | 1 | Mar 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $128 → $100 | $8.12 | +1,131.53% | 7 | Mar 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $60 → $90 | $68.26 | +31.85% | 7 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $140 | $58.00 | +141.38% | 21 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $90 | $35.35 | +154.60% | 8 | Feb 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $19.68 | +1.63% | 11 | Feb 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $32.03 | - | 1 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $175 | $170.88 | +2.41% | 11 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $3.70 | +602.70% | 11 | Sep 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $20 | $25.60 | n/a | 12 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $45 | $21.96 | n/a | 3 | Jan 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $15.05 | n/a | 2 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $44 → $50 | $100.23 | n/a | 2 | Mar 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.0001 | n/a | 2 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $5.24 | n/a | 5 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.8874 | n/a | 10 | Jul 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $24 | $16.26 | n/a | 1 | May 31, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $1.68 | n/a | 2 | May 15, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $115 → $123 | $39.61 | n/a | 7 | Jul 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $12 | $0.9866 | n/a | 1 | Jul 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $21 → $32 | $14.75 | n/a | 4 | Dec 12, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $54.87 | n/a | 6 | Oct 18, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $9.69 | n/a | 1 | Aug 13, 2014 |
DBV Technologies
Jul 17, 2026
Reiterated: Buy
Price Target: $51
Current: $14.70
Upside: +246.94%
Forte Biosciences
Jul 9, 2026
Reiterated: Buy
Price Target: $75
Current: $48.86
Upside: +53.50%
ABIVAX Société Anonyme
Jul 1, 2026
Reiterated: Buy
Price Target: $175
Current: $136.65
Upside: +28.06%
Praxis Precision Medicines
Jun 30, 2026
Maintained: Buy
Price Target: $800
Current: $314.41
Upside: +154.44%
Zura Bio
Jun 29, 2026
Maintained: Buy
Price Target: $15
Current: $5.45
Upside: +175.23%
EyePoint
Jun 24, 2026
Reiterated: Buy
Price Target: $68
Current: $13.30
Upside: +411.28%
argenx SE
Jun 24, 2026
Reiterated: Buy
Price Target: $1,135
Current: $860.55
Upside: +31.89%
Sionna Therapeutics
Jun 23, 2026
Reiterated: Buy
Price Target: $50
Current: $49.41
Upside: +1.19%
Climb Bio
Jun 8, 2026
Initiated Coverage: Buy
Price Target: $35
Current: $12.70
Upside: +175.59%
Zenas BioPharma
Jun 5, 2026
Maintained: Buy
Price Target: $55
Current: $29.53
Upside: +86.25%
Jun 1, 2026
Maintained: Buy
Price Target: $75 → $45
Current: $12.19
Upside: +269.16%
May 26, 2026
Maintained: Buy
Price Target: $44 → $62
Current: $40.26
Upside: +54.00%
May 26, 2026
Maintained: Buy
Price Target: $30 → $36
Current: $34.51
Upside: +4.32%
May 15, 2026
Reiterated: Buy
Price Target: $16
Current: $2.83
Upside: +465.37%
May 15, 2026
Reiterated: Buy
Price Target: $32 → $34
Current: $28.66
Upside: +18.63%
May 13, 2026
Maintained: Buy
Price Target: $15
Current: $3.54
Upside: +323.73%
May 8, 2026
Maintained: Buy
Price Target: $14
Current: $1.86
Upside: +654.72%
May 7, 2026
Maintained: Buy
Price Target: $60
Current: $29.05
Upside: +106.54%
May 7, 2026
Maintained: Buy
Price Target: $14
Current: $1.61
Upside: +769.57%
May 6, 2026
Maintained: Buy
Price Target: $50
Current: $19.37
Upside: +158.13%
May 6, 2026
Reiterated: Buy
Price Target: $200
Current: $105.60
Upside: +89.39%
May 4, 2026
Maintained: Buy
Price Target: $245 → $260
Current: $230.00
Upside: +13.04%
Apr 30, 2026
Maintained: Buy
Price Target: $975 → $995
Current: $676.69
Upside: +47.04%
Apr 30, 2026
Reiterated: Buy
Price Target: $25
Current: $10.94
Upside: +128.52%
Apr 29, 2026
Reiterated: Buy
Price Target: $246 → $260
Current: $205.99
Upside: +26.22%
Apr 27, 2026
Maintained: Buy
Price Target: $125 → $200
Current: $92.70
Upside: +115.75%
Mar 24, 2026
Initiated Coverage: Buy
Price Target: $70
Current: $15.16
Upside: +361.74%
Mar 13, 2026
Maintained: Buy
Price Target: $128 → $100
Current: $8.12
Upside: +1,131.53%
Mar 9, 2026
Reiterated: Buy
Price Target: $60 → $90
Current: $68.26
Upside: +31.85%
Mar 4, 2026
Reiterated: Buy
Price Target: $140
Current: $58.00
Upside: +141.38%
Feb 26, 2026
Reiterated: Buy
Price Target: $90
Current: $35.35
Upside: +154.60%
Feb 24, 2026
Maintained: Buy
Price Target: $20
Current: $19.68
Upside: +1.63%
Nov 18, 2025
Reiterated: Hold
Price Target: n/a
Current: $32.03
Upside: -
Oct 28, 2025
Reiterated: Buy
Price Target: $175
Current: $170.88
Upside: +2.41%
Sep 29, 2025
Reiterated: Buy
Price Target: $26
Current: $3.70
Upside: +602.70%
Feb 27, 2025
Maintained: Hold
Price Target: $20
Current: $25.60
Upside: n/a
Jan 3, 2025
Upgraded: Buy
Price Target: $45
Current: $21.96
Upside: n/a
Dec 11, 2024
Downgraded: Hold
Price Target: n/a
Current: $15.05
Upside: n/a
Mar 4, 2024
Maintained: Buy
Price Target: $44 → $50
Current: $100.23
Upside: n/a
Sep 21, 2023
Downgraded: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Aug 8, 2023
Reiterated: Hold
Price Target: n/a
Current: $5.24
Upside: n/a
Jul 17, 2023
Downgraded: Hold
Price Target: n/a
Current: $0.8874
Upside: n/a
May 31, 2022
Initiated Coverage: Buy
Price Target: $24
Current: $16.26
Upside: n/a
May 15, 2020
Reiterated: Buy
Price Target: $9
Current: $1.68
Upside: n/a
Jul 20, 2018
Reiterated: Buy
Price Target: $115 → $123
Current: $39.61
Upside: n/a
Jul 13, 2018
Initiated Coverage: Buy
Price Target: $12
Current: $0.9866
Upside: n/a
Dec 12, 2017
Reiterated: Buy
Price Target: $21 → $32
Current: $14.75
Upside: n/a
Oct 18, 2017
Rated: Buy
Price Target: n/a
Current: $54.87
Upside: n/a
Aug 13, 2014
Reiterated: Buy
Price Target: n/a
Current: $9.69
Upside: n/a